Francesco Fattirolli Selected Research

Cognitive Dysfunction

9/2022	Cardiac Rehabilitation in Advanced aGE after PCI for acute coronary syndromes: predictors of exercise capacity improvement in the CR-AGE ACS study.
2/2015	Clinical characteristics and course of patients with diabetes entering cardiac rehabilitation.
2/2014	Cardiac rehabilitation in chronic heart failure: data from the Italian SurveY on carDiac rEhabilitation (ISYDE-2008).
3/2003	[Recommendations for cardiovascular rehabilitation in the very elderly].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Fattirolli Research Topics

Disease

12	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 06/2007
10	Heart Failure 04/2021 - 03/2003
9	Myocardial Infarction 01/2016 - 01/2002
4	Acute Coronary Syndrome 09/2022 - 09/2013
4	Cognitive Dysfunction 09/2022 - 03/2003
3	Amyloidosis 10/2023 - 04/2021
3	Disease Progression 10/2023 - 02/2014
3	Heart Diseases (Heart Disease) 08/2023 - 03/2003
3	COVID-19 01/2021 - 06/2020
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2011 - 03/2003
2	Cardiomyopathies (Cardiomyopathy) 10/2023 - 04/2021
2	Frailty 08/2023 - 01/2021
2	Dementia (Dementias) 01/2021 - 05/2003
2	Hypertension (High Blood Pressure) 08/2020 - 03/2003
2	Diabetes Mellitus 08/2020 - 12/2003
2	Unstable Angina 01/2019 - 01/2016
2	Chronic Renal Insufficiency 02/2015 - 02/2014
2	Acute Kidney Injury (Acute Renal Failure) 02/2015 - 02/2014
2	Atrial Fibrillation 12/2013 - 06/2011
2	Obesity 09/2013 - 03/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2009 - 12/2005
1	Neoplasms (Cancer) 04/2024
1	Second Primary Neoplasms (Neoplasms, Second) 04/2024
1	Post-Acute COVID-19 Syndrome 10/2022
1	Musculoskeletal Diseases (Musculoskeletal Disease) 09/2022
1	Dyspnea (Shortness of Breath) 03/2022
1	Edema (Dropsy) 03/2022
1	Communicable Diseases (Infectious Diseases) 03/2021
1	Hypercholesterolemia 08/2020
1	Body Weight (Weight, Body) 01/2019
1	Stroke (Strokes) 01/2019
1	Non-ST Elevated Myocardial Infarction 01/2019
1	ST Elevation Myocardial Infarction 01/2019
1	Stable Angina 01/2019
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018
1	Infarction (Infarctions) 02/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2015
1	Peripheral Arterial Disease 02/2015
1	Cardiogenic Shock 09/2014
1	Respiratory Insufficiency (Respiratory Failure) 02/2014
1	Cardiac Arrhythmias (Arrythmia) 12/2013
1	Overweight 09/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2011
1	Death (Near-Death Experience) 01/2009
1	Atherosclerosis 12/2003

Drug/Important Bio-Agent (IBA)

3	Prealbumin (Transthyretin)IBA 10/2023 - 04/2021
3	Clostridium perfringens epsilon-toxinIBA 10/2023 - 04/2021
2	Amyloid (Amyloid Fibrils)IBA 10/2023 - 04/2021
2	LDL CholesterolIBA 01/2019 - 12/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2013 - 09/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2013 - 12/2003
2	Insulin (Novolin)FDA Link 12/2003 - 03/2003
1	Oxygen (Dioxygen)IBA 10/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2022
1	ThiazidesIBA 03/2022
1	DiureticsIBA 03/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 02/2021
1	CreatinineIBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	ElementsIBA 10/2018
1	SodiumIBA 01/2018
1	Ranolazine FDA Link 01/2018
1	SmokeIBA 07/2015
1	antineoplaston A10 (A 10)IBA 12/2013
1	Cardiovascular AgentsIBA 09/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2013
1	UbiquinoneIBA 04/2011
1	MicronutrientsIBA 04/2011
1	coenzyme Q10 (CoQ10)IBA 04/2011
1	CreatineIBA 04/2011
1	Dobutamine FDA LinkGeneric 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2003
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2003
1	Triglycerides (Triacylglycerol)IBA 12/2003
1	LipidsIBA 03/2003

Therapy/Procedure

23	Cardiac Rehabilitation 10/2023 - 01/2002
6	Secondary Prevention 08/2020 - 12/2005
5	Therapeutics 04/2024 - 12/2003
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 09/2014
2	Contraindications 09/2022 - 05/2003
2	Patient Readmission 03/2021 - 10/2018
1	Telerehabilitation 04/2024
1	Activities of Daily Living (ADL) 09/2022
1	Drug Therapy (Chemotherapy) 02/2015
1	Percutaneous Coronary Intervention 09/2014
1	Perioperative Period 03/2014
1	Stents 09/2011
1	Heart Transplantation (Grafting, Heart) 12/2009
1	Transplantation 12/2009